ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 55

$308K Total Retail Price of All Prescriptions

Rank: 20 out of 55

290 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

30% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

3% of this provider’s 5,184 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 560 196 S3 1 1
LEVOTHYROXINE SODIUM 232 201 2 3
OMEPRAZOLE 194 133 3 4
FUROSEMIDE 191 153 4 5
GABAPENTIN 154 81 5 10
METFORMIN HCL 143 105 6 8
METOPROLOL TARTRATE 139 117 7 14
SIMVASTATIN 132 118 8 6
LISINOPRIL 132 99 8 2
TRAMADOL HCL 129 116 10 13
HYDROCHLOROTHIAZIDE 124 103 11 15
FLUTICASONE PROPIONATE 122 101 12 46
PENTOXIFYLLINE 116 103 13 142
LANTUS 111 88 14 37
POTASSIUM CHLORIDE 110 88 15 7
CITALOPRAM HBR 102 66 16 12
MELOXICAM 88 79 17 11
SERTRALINE HCL 87 72 18 22
CEPHALEXIN 72 54 19 62
AMLODIPINE BESYLATE 69 59 20 9
TAMSULOSIN HCL 69 64 20 28
BUMETANIDE 68 68 22 103
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 58 22 70
ATORVASTATIN CALCIUM 66 56 24 19
METOPROLOL SUCCINATE 66 66 24 18
PANTOPRAZOLE SODIUM 61 48 26 72
ZOLPIDEM TARTRATE 58 47 27 17
LOSARTAN POTASSIUM 57 57 28 40
BACLOFEN 56 14 29 143
OXYCONTIN 54 0 S2 30 53
LOSARTAN-HYDROCHLOROTHIAZIDE 54 53 30 74
CLOTRIMAZOLE-BETAMETHASONE 53 50 32 143
WARFARIN SODIUM 53 37 32 21
CLONIDINE 52 52 34 193
TRAZODONE HCL 51 34 35 39
ALLOPURINOL 50 38 36 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.